英格兰炎症性关节炎患者的镇痛药处方:基于电子医疗记录数据的观察性研究
该研究利用英格兰九个全科诊所2000至2015年的初级保健数据,分析炎症性关节炎(IA)患者及匹配对照的年度镇痛药处方率。IA患者中多数(65.3%-78.5%)每年接受镇痛药,阿片类处方在2000至2015年间下降但仍常见,加巴喷丁类处方上升,口服NSAIDs下降,且IA患者处方率为对照的1.7-2.0倍。作者认为该现状与现有疗效风险证据及指南不一致,需要干预改善处方。
要点
- 2000至2015年,IA患者中65.3%-78.5%每年接受镇痛药,对照为37.5%-41.1%。
- 2015年32.9%的IA患者每年≥3次阿片类处方,加巴喷丁类处方从2000年0%升至2015年9.5%。
- 口服NSAIDs处方从2000年53.7%降至2015年25.0%,RA患者镇痛药处方比PsA/中轴SpA更常见。
核心结论
- 炎症性关节炎中镇痛药处方常见,与现有镇痛药疗效和风险证据及指南不一致,需要干预改善该人群的镇痛药处方。
研究设计与样本
- 研究为观察性研究,采用重复横断面分析,数据来自Consultations in Primary Care Archive中九个全科诊所2000至2015年的初级保健咨询与处方数据。
- 分析对象为IA病例(类风湿关节炎、银屑病关节炎或中轴脊柱关节炎)以及最多五名按年龄、性别和诊所匹配的对照。
- 镇痛药处方分为基础镇痛药、阿片类、加巴喷丁类和口服NSAIDs,并再分为慢性(每个日历年≥3次处方)和间歇(每个日历年1-2次处方)。
主要发现
- 2000年有594例病例和2652名对照,2015年增至1080例病例和4703名对照。
- 所有年份中多数(65.3%-78.5%)病例接受镇痛药,对照中接受镇痛药者较少(37.5%-41.1%)。
- 病例的阿片类处方在2000至2015年间下降,但2015年仍有45.4%(95%CI:42.4%,48.4%)接受至少1次阿片类处方,32.9%(95%CI:29.8%,36.0%)接受≥3次阿片类处方。
- 病例的加巴喷丁类处方患病率从2000年0%升至2015年9.5%(95%CI:7.9%,11.4%);口服NSAIDs处方患病率从2000年53.7%(95%CI:49.6%,57.8%)降至2015年25.0%(95%CI:22.4%,27.7%)。
- 各年份中,RA患者的镇痛药处方比PsA/中轴SpA更常见,病例的镇痛药处方率为对照的1.7-2.0倍。
关键数值与推荐
- 慢性镇痛药处方定义为每个日历年≥3次处方,间歇处方定义为每个日历年1-2次处方。
- 2015年病例中至少1次阿片类处方为45.4%(95%CI:42.4%,48.4%),≥3次为32.9%(95%CI:29.8%,36.0%)。
- 2015年病例中加巴喷丁类处方为9.5%(95%CI:7.9%,11.4%),口服NSAIDs为25.0%(95%CI:22.4%,27.7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: International data suggest inflammatory arthritis (IA) pain management frequently involves opioid prescribing, despite little evidence of efficacy, and potential harms. We evaluated analgesic prescribing in English National Health Service-managed patients with IA. METHODS: Repeated cross-sectional analyses in the Consultations in Primary Care Archive (primary care consultation and prescription data in nine general practices from 2000 to 2015) evaluated the annual prevalence of analgesic prescriptions in: (i) IA cases (RA, PsA or axial spondyloarthritis [SpA]), and (ii) up to five age-, sex- and practice-matched controls. Analgesic prescriptions were classified into basic, opioids, gabapentinoids and oral NSAIDs, and sub-classified into chronic and intermittent (≥3 and 1-2 prescriptions per calendar year, respectively). RESULTS: In 2000, there were 594 cases and 2652 controls, rising to 1080 cases and 4703 controls in 2015. In all years, most (65.3-78.5%) cases received analgesics, compared with fewer (37.5-41.1%) controls. Opioid prescribing in cases fell between 2000 and 2015 but remained common with 45.4% (95% CI: 42.4%, 48.4%) and 32.9% (95% CI: 29.8%, 36.0%) receiving at least 1 and ≥3 opioid prescriptions, respectively, in 2015. Gabapentinoid prescription prevalence in cases increased from 0% in 2000 to 9.5% (95% CI: 7.9%, 11.4%) in 2015, and oral NSAID prescription prevalence fell from 53.7% (95% CI: 49.6%, 57.8%) in 2000 to 25.0% (95% CI: 22.4%, 27.7%) in 2015. Across years, analgesic prescribing was commoner in RA than PsA/axial SpA, and 1.7-2.0 times higher in cases than controls. CONCLUSIONS: Analgesic prescribing in IA is common. This is at variance with existing evidence of analgesic efficacy and risks, and guidelines. Interventions are needed to improve analgesic prescribing in this population.
引用
- Scott IC, Bailey J, White CR, et al. Analgesic prescribing in patients with inflammatory arthritis in England: an observational study using electronic healthcare record data. Rheumatology (Oxford). 2022. PMID: 34849617. doi:10.1093/rheumatology/keab870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。